Dodick, David W.
https://orcid.org/0000-0002-9486-6790
Mayo Clinic
Atria Academy of Science and Medicine, New York, NY, United States
Citations 387
Randomized, Double-blind, Placebo-controlled Trial of ALD403, an anti-CGRP peptide antibody in the prevention of chronic migraine. (S52.003)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Dodick, David W. , Goadsby, Peter J. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
75% responder rates provide improvement in HIT-6 scores from week 4 through 12 following a single infusion of ALD403, or placebo. (P2.165)
Silberstein, Stephen D., Hirman, Joe, Smith, Jeff , Cady, Roger, Lipton, Richard B. , Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
A Brief Survey on Academic Headache Centers Knowledge of and Interest in ACGME recognition of Headache Medicine Fellowships (P1.203)
Rosen, Noah , Friedman, Deborah I. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available
Real World Efficacy, Tolerability and Safety of Ubrogepant (2485)
Arca, Karissa N., Dunn, R., Girardo, Marlene , Quillen, Jaxon , Starling, Amaal J. , Chiang, Chia‐Chun , Dodick, David W.
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Consistent efficacy and safety of erenumab over time in patients with episodic migraine who completed a 5-year, open-label extension study (2328)
Silberstein, Stephen D., Zhang, Feng, Xue, Fei , Cheng, Sunfa , Chou, Denise E. , Ashina, Messoud , Goadsby, Peter J. , Reuter, Uwe , Dodick, David W. , Zhang, Feng, Lima, Gabriel Paiva da Silva
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Impact of Abuse on Migraine Symptoms and Comorbidity: Results from the American Registry for Migraine Research (ARMR) (2187)
Trivedi, Meesha , Dumkrieger, Gina , Chong, Catherine D. , Dodick, David W. , Schwedt, Todd J.
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Risk of Hypertension in Erenumab-treated Patients With Migraine in Clinical Trials and in the Postmarketing Setting (2168)
Tepper, Stewart J. , Pannacciulli, Nico, Navetta, Marco S., Zhang, Feng, Choudhry, Jessica, Dodick, David W. , Ailani, Jessica , Xue, Fei , Zhang, Feng
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Use of Medical Education Program to Identify Practice Gaps Among Neurologists in the Use of Preventive Therapies for the Management of Migraine (1879)
Maeglin, John, Finnegan, Thomas , Dodick, David W.
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Consecutive Headache-Free Days With OnabotulinumtoxinA Treatment in Patients With Chronic Migraine: A Pooled PREEMPT Analysis (1841)
Sommer, Katherine , Silberstein, Stephen D., Diener, Hans‐Christoph , Dodick, David W. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available
Atogepant Improved Patient-Reported Migraine-Specific Quality of Life in a 12-Week Phase 3 (ADVANCE) Trial for Preventive Treatment of Migraine (1459)
Blumenfeld, Andrew , Severt, Lawrence, Stokes, Jonathan , Gandhi, Pranav , Dodick, David W. , Pozo‐Rosich, Patricia , Li, Ye , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available